GECo

The Global Excellence in COPD Outcomes project is a MRC funded collaboration assessing implementation of COPD case-finding and self-management in LMIC.

[GECo @COPDGECo]

Discriminative Accuracy of COPD Screening Instruments in Low- and Middle-Income Countries https://t.co/qT3zy46NQ9 via @JAMA_current part of @JAMANetwork

The main results of GECo1 are published today!

[GECo @COPDGECo]

It’s out!!!! Thank you to all our investigators, collaborators, field teams, supporters, participants and funders!

A thread from @ProfHurst explains the results….

[John Hurst @ProfHurst]

👀NEW!

Our @COPDGECo study 'COPD self-management in 3 LMICs: a pilot randomised trial' from @UCLmedsci is now online at @ATSBlueEditor...

🔗: https://t.co/eEBZNcJONE

[John Hurst @ProfHurst]

Great to see the @ATSBlueEditor special issue on #COPD out today, link below, and I’m super proud to be part of collaborations on two articles: unmet needs in LMIC setting from @COPDGECo, and a viewpoint on respiratory health in cities.

https://t.co/JnTASHAQrF

[John Hurst @ProfHurst]

👀🆕

Which interventions for #COPD have the greatest unmet need in low- and middle income country settings?

Read more in our latest @The_MRC funded @gacd_media work, the @COPDGECo study, now online @ATSBlueEditor:

https://t.co/vmTczdPj1Y

[John Hurst @ProfHurst]

It's a big day for the @COPDGECo team here @atscommunity #ATS2023 as Will Checkley presents the results of GECo2: our RCT of Community-Health Worker supported self-management for symptomatic #COPD across three LMIC settings in🇳🇵🇵🇪🇺🇬.

[IPCRG @IPCRG]

This IQ&A answer provides an overview of the prevalence of long COVID and the most common symptoms in the general population. It also describes special considerations for Asthma and COPD patients.
https://t.co/ReGNYFN8Jq
@atscommun @ginasthma @atscommunity #@GOLD_COPD @COPDGECo

[John Hurst @ProfHurst]

On behalf of the whole team, I’m privileged to be presenting our @COPDGECo results today at the @EuroRespSoc #ERS2022 @JAMA_current Symposium. Thread and link to paper below, or Hall 8B 930 CET and live streamed.

[GECo @COPDGECo]

The GECo team were thrilled to see our paper selected as ‘top five’ in the #ATS2022 COPD Clinical Year in Review.

Great recognition for our teams in 🇳🇵 🇵🇪 🇺🇬.

[GECo @COPDGECo]

Discriminative Accuracy of COPD Screening Instruments in Low- and Middle-Income Countries https://t.co/qT3zy46NQ9 via @JAMA_current part of @JAMANetwork

The main results of GECo1 are published today!

[John Hurst @ProfHurst]

⚠️NEW data from the @COPDGECo team now on line @ATSBlueEditor: “Cost-Accuracy Analysis of COPD Screening in Low- and Middle-Income Countries” | AJRCCM | Articles in Press https://t.co/yp0j8LO5Km

[UCL News @uclnews]

"The high prevalence of clinically significant disease was surprising & emphasises the need for a greater focus on chronic respiratory disease": @ProfHurst @uclmedsci on his global @COPDGECo study evaluating screening tools for #COPD. In @Reuters_Health https://t.co/7DnVzQGM7O

[GECo @COPDGECo]

Our 🇺🇬 site was expertly run from @Lung_Institute by @brucekirenga and @alupo_patricia. The prevalence of #COPD in rural Nakaseke was 7% and screening test accuracy was 76-82%. Only 12% @GOLD_COPD ‘A’. 17% ever smoked. More in our @JAMA_current paper: https://t.co/DmufY7ZL3N

[GECo @COPDGECo]

In Lima 🇵🇪 our work was led by @oscargffu and @jjaimemiranda in collaboration with @cronicasperu and @PrismaONG. The prevalence of #COPD here was 3% and screening tool accuracy was 72-91%. You can read more in the current issue of @JAMA_current. Here is our awesome field team🔽

[GECo @COPDGECo]

The results of our @The_MRC #COPD screening study found a prevalence of 18% in Bhaktapur, Nepal, and that simple tests identify a high-burden of important disease. Thanks to our incredible🇳🇵field team. Research led from @ucl by @ProfHurst.

@JAMA_current 👀https://t.co/DmufY7ZL3N

[GECo @COPDGECo]

Did you catch the editorial by Drs Yawn, Leidy and Martinez that accompanied our article… worth a read…

Screening for Chronic Obstructive Pulmonary Disease https://t.co/6cVOvb5tbb via @JAMA_current part of @JAMANetwork

[GECo @COPDGECo]

Watch this space… the results of our GECo1 study will be published this week..!

[John Hurst @ProfHurst]

This fantastic piece of mixed-methods research in @LancetGH by the @FRESHAIRTeam really emphasises the need to understand local context when designing and implementing interventions to target chronic respiratory disease in LMIC settings. 👀 ⬇️

https://t.co/FcYKlBxvZJ

[GECo @COPDGECo]

Latest from the GECo team:

[Annals of the ATS @AnnalsATS]

Development and Validity Assessment of a Chronic Obstructive Pulmonary Disease Knowledge Questionnaire in Low- and Middle-Income Countries

🔗 https://t.co/jFeHqDh2Ax

[John Hurst @ProfHurst]

It’s great to see our first @gacd_media @The_MRC @COPDGECo results being presented right now at @atscommunity #ATS2021. Abstract⬇️.

But, in truth, our hearts and thoughts are with friends and colleagues affected by #COVID19 at our field sites in Nepal, Peru and Uganda.
🇳🇵🇵🇪 🇺🇬

[GECo @COPDGECo]

It’s a big day for the GECo team as @TrishulMD presents the top line results from GECo1, our LMIC #COPD screening study at #ATS2021 - session C005 0800am EDT.

See you there!

[GECo @COPDGECo]

The GECo team are really excited to announce that our first results will be presented at @atscommunity #ATS2021 on 18th May by @TrishulMD. We *can’t wait*!